Back to 
Capital Research Global Investors
Capital Research Global Investors
TEVA
Showing 0 of 19 quarters
Position history for Capital Research Global Investors's holdings in TEVA PHARMACEUTICAL-SP ADR
No. Capital Research Global Investors exited its TEVA (Teva Pharmaceutical) position in Q2 2023. Its Q1 2023 13F listed 82,644,367 shares worth $731.4M. Capital Research Global Investors already held TEVA in its Q4 2018 13F, the earliest on record, and held it in 18 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.